NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 915-924

  Liu, Jian Li ^a,b   Ma, Hui Ping ^a   Lu, Xiu Li ^b   Sun, Shao Hua ^a   Gou, Xing ^a   Li, Fu Cai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY   (China)

Author keywords

CDK2; Centrosome amplification; Laryngeal squamous cell carcinoma; NF B

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CYCLIN DEPENDENT KINASE 2; FIREFLY LUCIFERASE; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR RELA;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARCINOGENESIS; CDK 2 GENE; CELL PROLIFERATION; CELL VIABILITY; CENTROSOME; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONSTRUCT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; LARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; SQUAMOUS CELL CARCINOMA; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CENTROSOME; CYCLIN-DEPENDENT KINASE 2; DNA-BINDING PROTEINS; GENE AMPLIFICATION; HEK293 CELLS; HUMANS; LARYNGEAL NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, SQUAMOUS CELL; NF-KAPPA B; NITRILES; PROMOTER REGIONS, GENETIC; PROTEIN SUBUNITS; SULFONES; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION;

EID: 79960889015     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1125     Document Type: Article

References (35)

1. Acilan C and Saunders WS: A tale of too many centrosomes. Cell 134: 572-575, 2008.
2. Saunders W: Centrosomal amplification and spindle multipolarity in cancer cells. Semin Cancer Biol 15: 25-32, 2005.
3. Jung CK, Jung JH, Lee KY, Kang CS, Kim M, Ko YH and Oh CS: Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins. Pathol Res Pract 203: 839-847, 2007. (Pubitemid 350048630)
4. Lengauer C, Kinzler KW and Vogelstein B: Genetic instability in colorectal cancers. Nature 386: 623-627, 1997. (Pubitemid 27175430)
5. Yamamoto Y, Eguchi S, Junpei A, et al: Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer. Cancer Genet Cytogenet 191: 38-42, 2009.
6. Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A and Raff JW: Centrosome amplification can initiate tumorigenesis in flies. Cell 133: 1032-1042, 2008. (Pubitemid 351787756)
7. Thompson SL, Bakhoum SF and Compton DA: Mechanisms of chromosomal instability. Curr Biol 20: 285-295, 2010.
8. Rajagopalan H and Lengauer C: Aneuploidy and cancer. Nature 432: 338-341, 2004. (Pubitemid 39551662)
9. Thompson SL and Compton DA: Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180: 665-672, 2008. (Pubitemid 351397764)
10. Ganem NJ, Godinho SA and Pellman D: A mechanism linking extra centrosomes to chromosomal instability. Nature 460: 278-282, 2009.
11. Gao C, Furge K, Koeman J, et al: Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci USA 104: 8995-9000, 2007. (Pubitemid 47175425)
12. Li Y, Li F, Li-Ling J, Wang X, Xu Z and Sun K: STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma. Cancer Invest 23: 660-664, 2005. (Pubitemid 43041712)
13. Niederberger E and Geisslinger G: Analysis of NF-kappaB signaling pathways by proteomic approaches. Expert Rev Proteomics 7: 189-203, 2010.
14. Chen F, Castranova V and Shi X: New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159: 387-397, 2001. (Pubitemid 32751067)
15. Pham LV, Tamayo AT, Yoshimura LC, Lo P and Ford RJ: Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol 171: 88-95, 2003. (Pubitemid 36745276)
16. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN and Price BD: Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18: 7389-7394, 1999. (Pubitemid 30032121)
17. Deorukhkar A and Krishnan S: Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol 80: 1904-1914, 2010.
18. Huang C, Huang K, Wang C, Jiang ZD, Li XX, Wang HP and Chen HY: Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Oncol Rep 22: 89-95, 2009.
19. Starska K, Stasikowska O, Lewy-Trenda I, Głowacka E and Łukomski M: Expression of transcription nuclear factor NFkappaB in laryngeal carcinoma tumor cells-correlation with IL-10 expression by blood mononuclear cells and clinicomorphological features. Otolaryngol Pol 63: 28-34, 2009.
20. Fukasawa K: Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6-19, 2005.
21. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P and Cleveland DW: Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36, 2007. (Pubitemid 46070223)
22. Marx J: Cell biology. Do centrosome abnormalities lead to cancer? Science 292: 426-429, 2001.
23. Krämer A: Centrosome aberrations-hen or egg in cancer initiation and progression? Leukemia 19: 1142-1144, 2005.
24. Krämer A, Neben K and Ho AD: Centrosome aberrations in hematological malignancies. Cell Biol Int 29: 375-383, 2005. (Pubitemid 40981996)
25. Nigg EA: Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2: 815-825, 2002.
26. D'Assoro AB, Lingle WL and Salisbury JL: Centrosome amplification and the development of cancer. Oncogene 21: 6146-6153, 2002.
27. Hinchcliffe EH and Sluder G: Two for two: Cdk2 and its role in centrosome doubling. Oncogene 21: 6154-6160, 2002.
28. Echalier A, Endicott JA and Noble ME: Recent developments in cyclin-dependent kinase biochemical and structural studies. Biochim Biophys Acta 1804: 511-519, 2010.
29. Matsumoto Y, Hayashi K and Nishida E: Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9: 429-432, 1999. (Pubitemid 29205787)
30. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K and Akiyama T: Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J Biol Chem 270: 23031-23037, 1995.
31. Marone M, Scambia G, Giannitelli C, et al: Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 75: 34-39, 1998. (Pubitemid 28113974)
32. Duensing A, Liu Y, Tseng M, Malumbres M, Barbacid M and Duensing S: Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 25: 2943-2949, 2006. (Pubitemid 43739245)
33. Long XE, Gong ZH, Pan L, et al: Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells. BMB Rep 43: 291-296, 2010.
34. Holubcová Z, Matula P, Sedláčková M, et al: Human embryonic stem cells suffer from centrosomal amplification. Stem Cells 29: 46-56, 2011.
35. Wang J, Liu X, Ni P, Gu Z and Fan Q: SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells. Biochem Biophys Res Commun 393: 291-296, 2010.